DONATE

NEWS

IMMONC at the ASCO 2024 Annual Meeting

View more

Update on the “Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone. Can This Modality Improve the Antiemetic Effect” trial

View more

Astghik Voskanyan presented recent developments of the BPDCN International Registry at the 29th Congress of EHA

View more

OncoDaily Leukemia Conference

View more

OncoThon 2024

View more

IMMONC Team at AOC 2024

View more

CLINICAL TRIAL APPROVAL GRANTED

View more

Amalya Sargsyan has been awarded the ASCO IDEA Award

View more

CLINICAL TRIAL UPDATE

View more

IMMONC annual report for 2023

View more

Amalya Sargsyan was granted an ESO Fellowship in Milan

View more

Introducing our Research Fellow, Dr. Lusine Harutyunyan

View more

Moffitt Cancer Center joins BPDCN International Registry

View more

IMMONC Research Fellowship Program-Armenia

View more

BPDCN Updates and Progress in 2023 – Naveen Pemmaraju

View more

The Children’s Welfare Teaching Hospital, University of Baghdad joins BPDCN international registry

View more